# Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.

Study · id `cardio:ct-nct03423511` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03423511](<https://clinicaltrials.gov/study/NCT03423511>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03423511

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1300 participants.

## Technical summary

Registry record NCT03423511. Randomized; single masking; primary purpose treatment. Start 2021-12-31 (anticipated); primary completion 2023-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1300 participants (planned count; ClinicalTrials.gov record NCT03423511, source copy `cardio:ctgov-nct03423511-2020-09-04`, retrieved 2026-10-26)
- Planned start: 2021-12-31 (anticipated) (ClinicalTrials.gov record NCT03423511, source copy `cardio:ctgov-nct03423511-2020-09-04`, retrieved 2026-10-26)
- Primary completion: 2023-06-01 (anticipated) (ClinicalTrials.gov record NCT03423511, source copy `cardio:ctgov-nct03423511-2020-09-04`, retrieved 2026-10-26)
- Completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT03423511, source copy `cardio:ctgov-nct03423511-2020-09-04`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03423511-2020-09-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
- Acronym: CRYSTAL
- Condition: Coronary Artery Disease
- Intervention (Device): MiStent II coronary artery stent
- Intervention (Device): Xience or Promus coronary artery stents
- Lead sponsor: Micell Technologies
- Lead sponsor class: INDUSTRY
- Collaborator: Baim Institute for Clinical Research
- Collaborator class: OTHER
- Collaborator: North American Science Associates Inc.
- Collaborator class: UNKNOWN
- Collaborator: Yale Cardiovascular Research Group
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Micell Technologies (`cardio:org-micell-technologies`)
- Registry lists this organization as a collaborator: Baim Institute for Clinical Research (`cardio:org-baim-institute-for-clinical-research`)
- Registry lists this organization as a collaborator: Yale Cardiovascular Research Group (`cardio:org-yale-cardiovascular-research-group`)

## Provenance

Content hash: 91045d6807c88d6c1f9c14a004503aa4391c63cf315a4bb4efc33c26904439ab
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
